Abstract
Recent investigations suggest that microthrombi formation in bowel capillaries could be a determinant factor in inflammatory bowel disease (IBD) pathogenesis. To evaluate the implication of the hemostatic system during these thrombotic events, we analyzed plasmatic values of prothrombotic state markers, physiologic inhibitors of coagulation, and endothelial lesion markers in 112 IBD patients. We found an increase in thrombin-antithrombin complexes and a decrease in antithrombin III, probably due to consumption, demonstrating an increase in thrombin generation. High levels ofd-dimer reflect increased fibrin formation, but there is no correlation between thrombin generation markers andd-dimer, possibly suggesting the presence of inadequate fibrinolysis. Levels of tissue factor pathway inhibitor were higher in patients than in controls. Nine patients with Crohn's disease (35% of our sample) had levels of this marker under 70% (range 37–69%). Von Willebrand factor values were increased and those of thrombomodulin only in active patients. Most of the changes were detected in patients with inflammatory activity, and there were no differences between ulcerative colitis and Crohn's disease. In conclusion, these results support the hypothesis that there is an endothelial lesion with sustained coagulation activation in IBD patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Jhons DR: Cerebrovascular complications of inflammatory bowel disease. Am J Gastroenterol 86:367–370, 1991
Lam A, Borda IT, Inwood MJ, Thomson S: Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology 68:245–251, 1975
Talbot RW, Heppell J, Dozois RR, Beart RW: Vascular complications of inflammatory bowel disease. Mayo Clin Proc 61:140–145, 1986
Lake AM, Stauffer JQ, Stuart MJ: Hemostatic alterations in inflammatory bowel disease. Response to therapy. Dig Dis 23:897–902, 1978
Knot EAR, ten Cate JW, Leeksma OCh, Tytgat GN, Vreeken J: No evidence for a prethrombotic state in stable chronic inflammatory bowel disease. J Clin Pathol 36:1387–1390, 1983
Lambrecht L, Baele G, Barbier F: Hemostatic alterations in Crohn's disease. Acta Clin Belg 42:1:5–11, 1987
Jorens PG, Hermans CR, Haber I, Kockx MM, Vermylen J, Parizel GA: Acquired protein C and S deficiency, inflammatory bowel disease and cerebral arterial thrombosis. Blut 61:307–310, 1990
Edwards RL, Levine JB, Green R, Duffy M, Mathews E, Brande W, Rickles FR: Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity. Gastroenterology 92:329–337, 1987
van Wersch JWJ, Houben P, Rijken J: Platelet count, platelet function, coagulation activity and fibrinolysis in the acute phase of inflammatory bowel disease. J Clin Chem Clin Biochem 28:513–517, 1990
Hudson M, Hutton RA, Wakefield AJ, Sawyer AM, Pounder RE: Evidence for activation of coagulation in Crohn's disease. Blood Coag Fibrinol 3:773–778, 1992
Stevens TRJ, James JP, Simmonds NJ, McCarthy DA, Laurenson IF, Maddison PJ, et al: Circulating von Willebrand factor in inflammatory bowel disease. Gut 33:502–506, 1992
Ryu T, Takazoe M, Inoue N, Ukai T, Seta K, Miyajima Y, Kazama M, Kinoshita T: Abnormalities of coagulation and fibrinolysis in patients with Crohn's disease. Thromb Haemostas 69:1060, 1993 (abstract)
Chitolie A, Hudson M, Wakefield AJ, Riddell A, Lee CA, Pounder RE: Tissue factor pathway inhibitor (TFPI) and factor VII in inflammatory bowel disease (IBD). Thromb Hacmostas 69:1081, 1993 (abstract)
Webberly MJ, Hart MT, Melikian V: Thromboembolism in inflammatory bowel disease: Role of platelets. Gut 34:247–251, 1993
Wakefield AJ, Dhillon AP, Rowles PM, Sawyerr AM, Pittilo RM, Lewis AAM, et al: Pathogenesis of Crohn's disease: Multifocal gastrointestinal infarction. Lancet 2:1057–1062, 1989
Leung FW, Koo A: Mucosal vascular stasis precedes loss of viability of endothelial cells in rat acetic acid colitis. Dig Dis Sci 36:727–732, 1991
Fairburn RA: On the actiology of ulcerative colitis. A vascular hypothesis. Lancet 2:697–699, 1973
Harvey RF, Bradshaw JM: A simple index of Crohn's disease activity. Lancet 1:514, 1980
Lichtiger S, Present DH: Preliminary report: Cyclosporin in treatment of severe active ulceration colitis. Lancet 336:16–19, 1990
Bauer KA, Rosenberg RD: The pathophysiology of the prethrombotic state in humans: Insights gained from studies using markers of hemostatic system activation. Blood 70:343–350, 1987
Declerck PJ, Mombaerts P, Holvoet P, de Mol M, Collen D: Fibrinolytic response and fibrin fragment D-dimer level in patients with deep vein thrombosis. Thromb Haemostas 58:1024–1029, 1987
de Jong E, Porte RJ, Knot EAR, Verheijen JH, Dees J: Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces. Gut 30:188–194, 1989
Conlan MG, Haire WD, Burnett DA: Prothrombotic abnormalities in inflammatory bowel disease. Dig Dis Sci 34:1089–1093, 1989
Gris JC, Schved JF, Raffanel C, Dubois A, Ribard D, Balmes JL: Réponse anormale au test d'occlusion veineuse chez les patients atteints de colite cryptogénique. Gastroenterol Clin Biol 15:933–938, 1991
Rosenberg RD, Bauer KA: Thrombosis in inherited deficiencies of antithrombin, protein C and protein S. Hum Pathol 18:253–262, 1987
Aadland E, Odegaard OR, Roseth A, Try K: Free protein S deficiency in patients with Crohn's disease. Scand J Gastroenterol 29:333–335, 1994
Tripodi A, Bertina RM, Connard J, Pabinger I, Sala N, Mannucci PM: Multicenter evaluation of three commerical methods for measuring protein S antigen. Thromb Haemostas 68:149–154, 1992
Broze GJ: Tissue factor pathway inhibitor and the revised hypothesis of blood coagulation. Trends Cardiovasc Med 2:72–77, 1992
Rappaport SI: The extrinsic pathway inhibitor: A regulator of tissue factor-dependent blood coagulation. Thromb Haemostas 66:6–15, 1991
Blann AD, Hopkins J, Winkles J, Wainwright AC: Plasma and serum von Willebrand factor antigen concentration in connective tissue disorders. Ann Clin Biochem 29:67–71, 1992
Takano S, Kimura S, Ohdama S, Aoki N: Plasma thrombomodulin in health and diseases. Blood 76:2024–2029, 1990
Dittman WA, Majerus PW: Structure and function of thrombomodulin: a natural anticoagulant. Blood 75:329–336, 1990
Ruggeri ZM, Ware J: The structure and function of von Willebrand factor. Thromb Haemostas 67:594–599, 1992
Wakefield AJ, Sankey EA, Dhillon AP, Sawyerr AFM, More L, Sim R, et al: Granulomatous vasculitis in Crohn's disease. Gastroenterology 100:1279–1287, 1991
Gaffney PR, O'Learny JJ, Doyle CT, Gaffney A, Hogan J, Smew F, et al: Response to heparin in patients with ulcerative colitis. Lancet 337:238–239, 1991 (letter)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Souto, J.C., Martínez, E., Roca, M. et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Digest Dis Sci 40, 1883–1889 (1995). https://doi.org/10.1007/BF02208650
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02208650